Abstract
The frequent failure to reduce the mortality due to epithelial cancers by common medical intervention results primarily from early dissemination of cancer cells, which is missed by conventional diagnostic procedures used for tumor staging. Individual carcinoma cells present in regional lymph nodes, blood or distant organs (e.g., bone marrow) can be detected by sensitive immunologic or molecular methods. Here, we review recently developed molecular assays for the detection of individual micrometastatic cancer cells and their clinical application in patients with epithelial tumors.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Belinsky, S.A., Nikula, K.J., Palmisano, W.A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S.B., and Herman, J.G. (1998). Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci. U. S. A 95, 11891–11896
Bostick, P.J., Chatterjee, S., Chi, D.D., Huynh, K.T., Giuliano, A.E., Cote, R., and Hoon, D.S. (1998). Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol. 16, 2632–2640
Brennan, J.A., Mao, L., Hruban, R.H., Boyle, J.O., Eby, Y.J., Koch, W.M., Goodman, S.N., and Sidransky, D. (1995). Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck [see comments]. N. Engl. J. Med. 332, 429–435
Chen, X., Bonnefoi, H., Diebold-Berger, S., Lyautey, J., Lederrey, C., Faltin-Traub, E., Stroun, M., and Anker, P. (1999). Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer [In Process Citation]. Clin. Cancer Res. 5, 2297–2303
Chen, X.Q., Stroun, M., Magnenat, J.L., Nicod, L.P., Kurt, A.M., Lyautey, J., Lederrey, C., and Anker, P. (1996). Microsatellite alterations in plasma DNA of small cell lung cancer patients [see comments]. Nat. Med. 2, 1033–1035
Cheung, I.Y., Cheung, N.K., Ghossein, R.A., Satagopan, J.M., Bhattacharya, S., and Coit, D.G. (1999). Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study [In Process Citation]. Clin. Cancer Res. 5, 2042–2047
Czegledy, J., Iosif, C., Hansson, B.G., Evander, M., Gergely, L., and Wadell, G. (1995). Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer ? Int. J. Cancer 64, 211–215
De la, T.A., Olsson, C.A., and Katz, A.E. (1999). Molecular staging of prostate cancer: dream or reality? Oncology (Huntingt) 13, 187–194
Denis, M.G., Lipart, C., Leborgne, J., LeHur, P.A., Galmiche, J.P., Denis, M., Ruud, E., Truchaud, A., and Lustenberger, P. (1997). Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients. Int. J. Cancer 74, 540–544
Fujiwara, Y., Chi, D.D., Wang, H., Keleman, P., Morton, D.L., Turner, R., and Hoon, D.S. (1999). Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res. 59, 1567–1571
Ghossein, R.A., Bhattacharya, S., and Rosai, J. (1999a). Molecular detection of micrometastases and circulating tumor cells in solid tumors [In Process Citation]. Clin. Cancer Res. 5 1950–1960
Ghossein, R.A., Bhattacharya, S., and Rosai, J. (1999b). Molecular detection of micrometastases and circulating tumor cells in solid tumors [In Process Citation]. Clin. Cancer Res. 5 1950–1960
Ghossein, R.A., Coit, D., Brennan, M., Zhang, Z.F., Wang, Y., Bhattacharya, S., Houghton, A., and Rosai, J. (1998). Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin. Cancer Res. 4, 419–428
Ghossein, R.A., Rosai, J., Scher, H.I., Seiden, M., Zhang, Z.F., Sun, M., Chang, G., Berlane, K., Krithivas, K., and Kantoff, P.W. (1997). Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma. Urology 50, 100–105
Goessl, C., Heicappell, R., Munker, R., Anker, P., Stroun, M., Krause, H., Muller, M., and Miller, K. (1998). Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res. 58, 4728–4732
Hayashi, N., Arakawa, H., Nagase, H., Yanagisawa, A., Kato, Y., Ohta, H., Takano, S., Ogawa, M., and Nakamura, Y. (1994). Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res. 54, 3853–3856
Hayashi, N., Ito, I., Yanagisawa, A., Kato, Y., Nakamori, S., Imaoka, S., Watanabe, H., Ogawa, M., and Nakamura, Y. (1995). Genetic diagnosis of lymph-node metastasis in colorectal cancer [see comments]. Lancet %20; 345, 1257–1259
Hibi, K., Robinson, C.R., Booker, S., Wu, L., Hamilton, S.R., Sidransky, D., and Jen, J. (1998). Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res. 58, 1405–1407
Izbicki, J.R., Hosch, S.B., Pichlmeier, U., Rehders, A., Busch, C., Niendorf, A., Passlick, B., Broelsch, C.E., and Pantel, K. (1997). Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer [see comments]. N. Engl. J. Med. 337, 1188–1194
Jung, R., Ahmad-Nejad, P., Wimmer, M., Gerhard, M., Wagener, C., and Neumaier, M. (1997). Quality management and influential factors for the detection of single metastatic cancer cells by reverse transcriptase polymerase chain reaction. Eur. J. Clin. Chem. Clin. Biochem. 35, 3–10
Jung, R., Kruger, W., Hosch, S., Holweg, M., Kroger, N., Gutensohn, K., Wagener, C., Neumaier, M., and Zander, A.R. (1998). Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br. J. Cancer 78, 1194–1198
Keilholz, U. (1998). New prognostic factors in melanoma: mRNA tumour markers. Eur. J. Cancer 34 Suppl 3:S37–41, S37–S41
Kobayashi, Y., Yoshinouchi, M., Tianqi, G., Nakamura, K., Hongo, A., Kamimura, S., Mizutani, Y., Kodama, J., Miyagi, Y., and Kudo, T. (1998). Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes. Clin. Cancer Res. 4, 979–983
Kubuschok, B., Passlick, B., Izbicki, J.R., Thetter, O., and Pantel, K. (1999). Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-smallcell lung cancer. J. Clin. Oncol. 17 19–24
Liefers, G.J., Cleton-Jansen, A.M., van de Velde, C.J., Hermans, J., van Krieken, J.H., Corne-lisse, C.J., and Tollenaar, R.A. (1998). Micrometastases and survival in stage II colorectal cancer [see comments]. N. Engl. J. Med. 339, 223–228
Mao, L., Schoenberg, M.P., Scicchitano, M., Erozan, Y.S., Merlo, A., Schwab, D., and Sidransky, D. (1996). Molecular detection of primary bladder cancer by microsatellite analysis. Science 271, 659–662
Mellado, B., Colomer, D., Castel, T., Munoz, M., Carballo, E., Galan, M., Mascaro, J.M., Vives-Corrons, J.L., Grau, J.J., and Estape, J. (1996). Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J. Clin. Oncol. 14, 2091-C
Mellado, B., Gutierrez, L., Castel, T., Colomer, D., Fontanillas, M., Castro, J., and Estape, J. (1999). Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients. Clin. Cancer Res. 5, 1843–1848
Millon, R., Jacqmin, D., Muller, D., Guillot, J., Eber, M., and Abecassis, J. (1999). Detection of Prostate-Specific Antigen-or Prostate-Specific Membrane Antigen-Positive Circulating Cells in Prostatic Cancer Patients: Clinical Implications. Eur. Urol. 36, 278–285
Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. (1996). Microsatellite alterations in serum DNA of head and neck cancer patients [see comments]. Nat. Med. 2, 1035–1037
Oefelein, M.G., Ignatoff, J.M., Clemens, J.Q., Watkin, W., and Kaul, K.L. (1999). Clinical and molecular followup after radical retropubic prostatectomy. J. Urol. 162, 307–310
Raj, G.V., Moreno, J.G., and Gomella, L.G. (1998). Utilization of polymerase chain reaction technology in the detection of solid tumors [see comments]. Cancer 82, 1419–1442
Sanchez-Cespedes, M., Esteller, M., Hibi, K., Cope, F.O., Westra, W.H., Piantadosi, S., Herman, J.G., Jen, J., and Sidransky, D. (1999b). Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence [In Process Citation]. Clin. Cancer Res. 5, 2450–2454
Sanchez-Cespedes, M., Esteller, M., Hibi, K., Cope, F.O., Westra, W.H., Piantadosi, S., Herman, J.G., Jen, J., and Sidransky, D. (1999a). Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence [In Process Citation]. Clin. Cancer Res. 5, 2450–2454
Sanchez-Cespedes, M., Monzo, M., Rosell, R., Pifarre, A., Calvo, R., Lopez-Cabrerizo, M.P., and Astudillo, J. (1998). Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann. Oncol. 9, 113–116
Sidransky, D. (1997). Nucleic acid-based methods for the detection of cancer. Science 278, 1054–1059
Soeth, E., Vogel, I., Roder, C., Juhl, H., Marxsen, J., Kruger, U., Henne-Bruns, D., Kremer, B., and Kalthoff, H. (1997). Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res. 57, 3106–3110
von Knebel, Doeberitz, M. and Lacroix, J. (1999). Nucleic acid based techniques for the detection of rare cancer cells in clinical samples. Cancer Metastasis Rev. 18, 43–64
Weitz, J., Kienle, P., Lacroix, J., Willeke, F., Benner, A., Lehnert, T., Herfarth, C., and von Knebel Doeberitz, M. (1998). Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin. Cancer Res. 4, 343–348
Weitz, J., Kienle, P., Magener, A., Koch, M., Schrodel, A., Willeke, F., Autschbach, E, Lacroix, J., Lehnert, T., Herfarth, C., and von Knebel Doeberitz, M. (1999). Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin. Cancer Res. 5, 1830–1836
Willeke, F., Mechtersheimer, G., Schwarzbach, M., Weitz, J., Zimmer, D., Lehnert, T., Herfarth, C., von Knebel Doeberitz, M., and Ridder, R. (1998a). Detection of SYTSSX1/2 fusion transcripts by reverse transcriptase-polymerase chain reaction (RT-PCR) is a valuable diagnostic tool in synovial sarcoma. Eur. J. Cancer 34, 2087–2093
Willeke, E, Ridder, R., Mechtersheimer, G., Schwarzbach, M., Duwe, A., Weitz, J., Lehnert, T., Herfarth, C., and von Knebel Doeberitz, M. (1998b). Analysis of FUS-CHOP fusion transcripts in different types of soft tissue liposarcoma and their diagnostic implications. Clin. Cancer Res. 4, 1779–1784
Zippelius, A., Kufer, P., Honold, G., Kollermann, M.W., Oberneder, R., Schlimok, G., Riethmuller, G., and Pantel, K. (1997). Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow [see comments]. J. Clin. Oncol. 15, 2701–2708
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
von Knebel Doeberitz, M., Weitz, J., Koch, M., Lacroix, J., Schrödel, A., Herfarth, C. (2001). Molecular Tools in the Detection of Micrometastatic Cancer Cells — Technical Aspects and Clinical Relevance. In: Reinhold, U., Tilgen, W. (eds) Minimal Residual Disease in Melanoma. Recent Results in Cancer Research, vol 158. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59537-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-59537-0_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64015-5
Online ISBN: 978-3-642-59537-0
eBook Packages: Springer Book Archive